Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LYPLA2 |
| Upstream (Parents) |
|---|
| (<<) EPHB2 → LYPLA2 |
| (<<) GNAI1 → LYPLA2 |
| (<<) ITPR1 → LYPLA2 |
| (<<) ITPR3 → LYPLA2 |
| (<<) KHDRBS1 → LYPLA2 |
| (<<) MAPK13 → LYPLA2 |
| (<<) NFAT5 → LYPLA2 |
| (<<) PPP1CA → LYPLA2 |
| (<<) PPP1R11 → LYPLA2 |
| (<<) PRKCZ → LYPLA2 |
| (<<) PYGB → LYPLA2 |
| (<<) RDX → LYPLA2 |
| (<<) RPS6KA1 → LYPLA2 |
| (<<) SOCS2 → LYPLA2 |
| Downstream (Children) |
|---|
| LYPLA2 → CASP10 (>>) |
| LYPLA2 → CBL (>>) |
| LYPLA2 → CCND3 (>>) |
| LYPLA2 → DVL1 (>>) |
| LYPLA2 → ELF5 (>>) |
| LYPLA2 → HDAC3 (>>) |
| LYPLA2 → HLA-DOA (>>) |
| LYPLA2 → NEUROG3 (>>) |
| LYPLA2 → RHBDL1 (>>) |
